Emmessar Biotech Stock Screener | Share Price & Fundamental Analysis
EMMESSA
Commodity Chemicals
Screen Emmessar Biotech share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹29.34
▼
-0.92 (-3.04%)
Market Cap
₹15.04 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.77
EPS (TTM)
₹0.63
Dividend Yield
-
Debt to Equity
0.01
52W High
₹45.69
52W Low
₹26.41
Operating Margin
-331.00%
Profit Margin
-
Revenue (TTM)
₹2.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹9.00
Total Equity
₹8.00
Emmessar Biotech Share Price History - Stock Screener Chart
Screen EMMESSA historical share price movements with interactive charts. Analyze price trends and patterns.
Emmessar Biotech Company Profile - Fundamental Screener
Screen Emmessar Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for EMMESSA shares.
Sector
Chemicals
Industry
Commodity Chemicals
Sub-Sector
Commodity Chemicals
Segment
E
ISIN
INE634B01016
Emmessar Biotech Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen EMMESSA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 9 | 9 | 8 | 7 | 8 | 6 | 5 | 4 | 3 | 2 |
| Current Assets | 7 | 7 | 6 | 5 | 5 | 3 | 2 | 1 | 1 | 1 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Liabilities | ||||||||||
| Total Liabilities | 9 | 9 | 8 | 7 | 8 | 6 | 5 | 4 | 3 | 2 |
| Current Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 8 | 7 | 7 | 6 | 6 | 4 | 4 | 3 | 2 | 1 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 3 | 2 | 2 | 1 | 1 | -1 | -2 | -2 | -3 | -4 |
Screen EMMESSA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 3 | 3 | 3 | 2 | 9 | 5 | 2 | 3 | 4 | 2 | 2 |
| Expenses | 2 | 2 | 2 | 2 | 1 | 6 | 4 | 1 | 2 | 2 | 2 | 2 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
| Operating Profit % | -331.00% | -156.00% | -195.00% | -68.00% | -245.00% | 12.00% | -12.00% | -102.00% | -32.00% | 9.00% | 1.00% | -7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | -1 | 0 |
| Tax | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -1 | 0 |
| EPS | 0.40 | 0.63 | 1.50 | 0.99 | 0.94 | 2.90 | 1.51 | 1.05 | 1.83 | 2.36 | -0.93 | -0.24 |
Emmessar Biotech Cash Flow Screener - Liquidity Fundamentals
Screen EMMESSA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 1 | 0 | 2 | 1 | 1 | 0 | 1 | 1 | 0 |
| Investing Activities | 0 | -1 | -1 | -3 | 0 | -1 | 0 | -1 | -1 | -1 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Screen EMMESSA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% | 59.08% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 37.15% | 37.14% | 38.12% | 37.94% | 37.64% | 37.48% | 37.09% | 38.38% |
| Other Holding | 3.12% | 3.14% | 2.16% | 2.33% | 2.64% | 2.80% | 3.19% | 2.35% |
| Shareholder Count | 7,180 | 7,173 | 7,350 | 7,146 | 6,900 | 6,936 | 7,186 | 6,933 |
Emmessar Biotech Dividend Screener - Share Yield Analysis
Screen EMMESSA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Emmessar Biotech Index Membership - Market Screener Classification
Screen EMMESSA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Emmessar Biotech Market Events Screener - Corporate Actions
Screen EMMESSA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 23.37% | ||
| Annual General Meeting | NA | 7.42% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.36% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -4.34% |
| 2025-04-24 | 2025-04-24 | Quarterly Result Announcement | NA | 6.06% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 7.24% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 43.67% |
Emmessar Biotech Competitors Screener - Peer Comparison
Screen EMMESSA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Tata Chemicals | 19,578 | 48.48 | 15,112 | -3.79% | 354 | 39.14 |
| Deepak Fertilisers & Petrochemicals | 15,604 | 15.38 | 10,355 | 17.69% | 945 | 37.94 |
| Gujarat Narmada Valley Fert & Chem | 7,178 | 11.23 | 8,393 | -0.07% | 586 | 42.46 |
| GHCL | 5,457 | 9.21 | 3,271 | -6.51% | 624 | 40.85 |
| Blue Pearl Agriventures | 5,380 | 9397.00 | 35 | 11666.67% | 1 | 45.51 |
| Tanfac Industries | 4,324 | 44.85 | 560 | 45.35% | 88 | 66.95 |
| Chemplast Sanmar | 4,201 | -17.96 | 4,393 | 9.61% | -110 | 35.65 |
| Gujarat Alkalies & Chemicals | 3,709 | 25292.50 | 4,165 | 6.89% | -65 | 34.82 |
| Grauer & Weil | 3,398 | 22.51 | 1,180 | 7.28% | 157 | 33.82 |
| Fischer Medical Ventures | 2,791 | 141.48 | 112 | 421.86% | 1 | 30.56 |
Emmessar Biotech Company Announcements - News Screener
Screen EMMESSA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-13 | Newspaper Add | View |
| 2025-11-12 | Results For Quarter Ended September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended Sept 30 2025 | View |
| 2025-11-06 | Board Meeting Intimation for Considering Unaudited Results For The Quarter Ended September 30 2025 | View |
| 2025-10-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-04 | Newspaper Add For Completion Of Dispatch Of Annual Reports | View |
| 2025-09-03 | Reg. 34 (1) Annual Report. | View |
| 2025-09-03 | Notice Of The 33Rd Annual General Meeting To Be Held On Friday 26Th September 2025 At 10:30 A.M. (IST). | View |
| 2025-08-28 | Newspaper Add - For Holding AGM Through VC | View |
| 2025-08-08 | Newspaper Add For Unaudited Financial Results For The Quarter Ended June 2025 | View |
| 2025-08-07 | Results For Quarter Ended June 30 2025 | View |
| 2025-08-07 | Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For Quarter Ended June 30 2025 | View |
| 2025-08-02 | Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2025 | View |
| 2025-07-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-06-29 | Closure of Trading Window | View |
| 2025-04-25 | Newspaper Add | View |
| 2025-04-24 | Results For The Period Ended March 31 2025 | View |